- Home
- LPL vs DYN Comparison
LPL vs DYN Comparison
Compare LPL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPL | DYN |
|---|---|---|
| Founded | 1985 | 1984 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.9B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LPL | DYN |
|---|---|---|
| Price | $3.17 | $24.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | N/A | ★ $37.00 |
| AVG Volume (30 Days) | ★ 3.1M | 2.6M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.35 | N/A |
| Revenue Next Year | $2.94 | N/A |
| P/E Ratio | $25.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.16 | $8.88 |
| 52 Week High | $5.83 | $25.00 |
Technical Indicators
Market Signals| Indicator | LPL | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 33.43 | 63.30 |
| Support Level | N/A | $16.47 |
| Resistance Level | $4.37 | $24.52 |
| Average True Range (ATR) | 0.14 | 1.46 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 5.97 | 84.68 |
Price Performance
Historical ComparisonAbout LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.